Next Generation Sequencing Market Outlook 2026–2034: How Genomics Is Revolutionizing Precision Medicine and Disease Diagnostics

vocal.media· June 14, 2026

Next Generation Sequencing Market Outlook 2026–2034: How Genomics Is Revolutionizing Precision Medicine and Disease Diagnostics vocal.media

Read the full story at vocal.media

Summary generated by RabbitReport AI from public reporting. The full article and original reporting belong to vocal.media.

More in Genomics & Precision Medicine

Precision Medicine Software Market | Industry Report, 2033

Precision Medicine Software Market | Industry Report, 2033 Grand View Research

June 14, 2026

Precision Medicine Market Size Surges Toward USD 470.53 Billion by 2034 Driven by Targeted Therapies and Genomic Innovation

The global precision medicine market is projected to grow from USD 119.03 billion in 2025 to approximately USD 470.53 billion by 2034, representing a compound annual growth rate of 16.50%. This rapid expansion is fueled by breakthroughs in genomics, molecular diagnostics, and AI-driven data analysis that enable personalized treatment strategies tailored to individual genetic profiles. The sector's growth is particularly significant for the management of chronic diseases and oncology, where targeted therapies are increasingly replacing traditional one-size-fits-all medical approaches.

June 14, 2026

Global Precision Medicine Market Growth Accelerates at 16.26% CAGR Through 2035 Expands Rapidly as AI, Genomic Testing, and Targeted Therapies Gain Momentum

Global Precision Medicine Market Growth Accelerates at 16.26% CAGR Through 2035 Expands Rapidly as AI, Genomic Testing, and Targeted Therapies Gain Momentum Yahoo Finance

June 14, 2026

Personalized Medicine Market Size, Share | Growth Report[2034]

The global personalized medicine market is valued at $214.44 billion in 2025 and is projected to reach $587.02 billion by 2034, growing at a CAGR of 12.19%. This growth is primarily fueled by the increasing adoption of companion diagnostics, genomic testing, and biomarker-driven targeted therapies that enhance disease identification and treatment oversight. For the genomics and precision medicine sector, these trends represent a fundamental shift toward data-driven healthcare that prioritizes individual patient profiles over universal treatment models.

June 14, 2026